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Contact inhibition of locomotion (CIL) occurs when a cell ceases moving in the same direction fol-
lowing contact with another cell. Homotypic and heterotypic CIL occur between cells of the same
and different types, respectively. Using Abercrombie’s confronted explants assay we studied the
effect of changing Rac1 or RhoA activities on heterotypic CIL between NIH3T3 and chicken heart
ﬁbroblasts. Both dominant active (L61) and dominant negative (N17) Rac1 expressed in NIH3T3 cells
resulted in loss of heterotypic CIL. N17Rac1 expression caused RhoA activation. Increasing RhoA
activity directly (V14RhoA) or indirectly (downregulation of N-cadherin or p120-catenin) also
resulted in loss of CIL. High RhoA activity has been associated with tumour invasion and our results
are consistent with loss of heterotypic CIL playing a role.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Contact inhibition of locomotion (CIL; also denoted contact
inhibition of movement) is believed to play a role in many aspects
of cell social behavior, including tumour invasiveness, embryonic
development and wound healing. As deﬁned by Abercrombie and
colleagues [1,2], CIL originally referred to heterotypic collisions be-
tween motile cells in culture. Heterotypic CIL occurs between cells
of different types but can occur in vitro between cells of the same
types but from different species, such as, mouse and chicken heart
ﬁbroblasts [1]. Homotypic CIL occurring between cells of the same
type has also been described, for example between migrating neu-
ral crest (NC) cells in vitro and in vivo [3]. Malignant sarcoma and
melanoma cells have been shown to have lost CIL when confronted
with normal ﬁbroblasts [4,5] but retain homotypic CIL. Contact
inhibition of proliferation is a different process, involving cessation
of proliferation when cells contact other cells [2].
CIL involves cell–cell contact, inhibition of cell protrusion
activities at the contact site, new protrusions forming away from
the contact site and cell migration occurring in the direction of
the new protrusion [2]. Hence, a change in direction of movement
results from collision between two different cells, the net effect
being that the cells migrate away from each other and the two cell
populations fail to mix [6]. The degree of contact inhibition
between two cell populations was originally studied usingchemical Societies. Published by E
sh).confronted explants [1]. The collision behavior of ﬁbroblasts
migrating from two explants was determined, including speed of
movement in relation to the number of contacts and the extent
of nuclear overlap. Individual collisions have been studied using
time lapse [7,8].
The Wnt Planar Cell Polarity (PCP or non-canomical) pathway is
required for homotypic CIL between migrating NC cells [3].
Elements of the pathway become co-localized at the site of cell
contact. Wnt signaling leads to an increase in RhoA activity in this
region. Inhibition of ROCK, a downstream target of RhoA, results in
loss of NC cell CIL. The assembly of actin:myosin ﬁlaments is reg-
ulated by Rho, thereby generating contractile forces [9]. Whether
activated RhoA causes inhibition of protrusion via contractile
forces or by other means is not known.
Inhibition of N-cadherin on NC cells prevented homotypic CIL,
cells exhibiting no change of direction following contact [10]. An
increase in Rac1 occurs at the juxtamembrane domain of NC cells
in which N-cadherin is inhibited. RhoA activation via the Wnt/
PCP pathway fails to occur and this failure may be responsible
for the increased Rac1 activity.
Abercrombie and colleagues used the confronted explant assay
to study heterotypic CIL between chicken heart ﬁbroblasts (CHF)
and various ﬁbroblast cell lines [1]. In this study we used the assay
to examine the effects of changing RhoA activity or reducing N-
cadherin levels on the heterotypic CIL between CHF and NIH3T3
ﬁbroblasts. Actin polymerization at the cell periphery is promoted
by Rac and Cdc42, resulting in the generation of protrusive forces
and the formation of lamellipodia and ﬁlipodia [9]. Hence, we alsolsevier B.V. All rights reserved.
E. Anear, R.W. Parish / FEBS Letters 586 (2012) 1330–1335 1331studied the effects on heterotypic CIL of changing Rac1 and Cdc42
activities.
2. Materials and methods
2.1 Confronted explants assay
The Abercrombie confronted explants assay was carried out
using chicken heart ﬁbroblasts and NIH3T3 cells as previously
described [8,11]. The bottom third of the hearts removed from
the embryos of 7 day old fertilized chicken eggs was excised
and placed in a dish of fresh DMEM. The excised heart tissue
was cut into 4–5 explants on glass slide(s) and each explant
placed in a well of a 24 well plate. After an hour at RT the chick-
en heart ﬁbroblast explants were placed in a 37 C incubator (5%
CO2). Explants were left for 48 h to allow the ﬁbroblasts to mi-
grate out in a ring around the explant (primary explant). The
NIH3T3 cell lines were grown to conﬂuency and scraped using
a rubber policeman to form the secondary explants. Each explant
was rinsed in DMEM and placed next to the established primary
explant with 1 mm distance between the two explants. After 1 h
the explants were placed in the incubator (37 C, 5% CO2). After
24 h explants were examined to determine which secondary ex-
plants had made contact with the primary explants. Measure-
ments to determine the invasion index were made 24 h after
contact between the two explants had occurred. The cell move-
ment into free space around the secondary explants was mea-
sured at three points as was the distance moved from the point
of contact with the CHF (Supplementary Fig. 1). Importantly, all
the cell lines used retained a ﬁbroblast-like (cf. amoeboid) phe-
notype and rates of migration, including following inhibitor treat-
ments, remained similar to the controls. The inhibitors were
added when the ﬁrst contact between CHF and NIH3T3 cells
had occurred. The ROCK and Rac inhibitors Y-27632 and
NSC23766 were initially tested at manufacturer recommended
doses which were found to be toxic. Kill curves were determined
for the range 100–5 lM and the highest dose when cell growth
was unaffected (25 lM) employed for the confronted explants
assays.Table 1
Effect of dominant active L61Rac1 on the invasion index of NIH3T3 and EcR/3T3 cells.
(a) Two lines transfected with constitutively expressed L61Rac1. NIH3T3/VV4 is the
empty vector control line. (b) A EcR/3T3 cell line in which L61Rac1 expression is
driven by an ecdysone promoter. Expression was induced by Ponasterone A
treatment.
Cell line n Mean invasion index ± std error p-value
(a)
L61(1) 25 0.53 ± 0.02 0.01
L61(2) 25 0.51 ± 0.02 0.04
NIH3T3/VV4 41 0.44 ± 0.02
(b)
L61Rac1 + PonA 42 0.65 ± 0.03 0.00
L61Rac1 45 0.44 ± 0.022.1. Genes, vectors and cloning
Genes and their vectors were: dominant negative N17Rac1
pGEM and constitutively active L61Rac1(ampr) pRK5NYC, V14RhoA
pGEM (all fromDr. A. Hall, Memorial Sloan-Kettering Cancer Center,
New York); p190RhoA MPEG – retroviral vector with the RhoGAP
domain of p190RhoGAP fused with C-terminal hypervariable se-
quences of RhoA or RhoC (from Dr. Y. Zheng, University of Cincin-
nati); dominant negative N17Cdc42 and a constitutively active
V12Cdc42 in pcDNA3.1 (cDNA Resource Centre, Missouri); pEGFP-
mDiaDN3Kanr, dominant active truncation mutant of mouse mDia
(from Dr. S. Narumiya, Kyoto University); antisense Tiam1pcDNA3,
500 bp antisense fragment of human Tiam1 (from Dr. L. Tan, Fudan
University). The primer sequences used are shown in Supplemen-
tary Table 1.
Cells were transfected using the Dosper Liposomal Transfection
Reagent (Roche) and antibiotic selection used to isolate cell clones.
Genomic DNA and mRNA were isolated using the DNeasy Kit and
RNeasy Kit from QIAGEN, respectively.
2.2. Cell lines and RhoA activity assay
Details of the cell lines used are provided in Supplementary
Table 2. RhoA activity was determined using the ELISA based
G-LISA RhoA Activation Biochem Kit (colorimetric format) (Cyto-
skeleton Inc.) according to the manufacturer’s instructions.2.3. Statistics
A minimum of 15 confronted explants were measured for each
cell line to establish the averaged invasion index. When experi-
ments were repeated with a particular cell line, data between trials
was analysed by one-way ANOVA or Tukey’s HSD to ensure there
was no signiﬁcant difference between the experiments. Compari-
sons between transformed clones and controls were analysed by
Dunnet’s t-test.
3. Results
3.1. Effects of changing Rac1 activity
NIH3T3 cells were transfected with L61Rac1 (dominant-active
Rac1). Two lines were isolated and, using the confronted ex-
plants assay, their invasive indices compared with a line
(NIH3T3/VV4) transfected with the empty vector. Both L61Rac1
lines showed statistically signiﬁcant increases in invasion indices
(Table 1a). RT-PCR conﬁrmed L61Rac1 was expressed in both
lines (Supplementary Fig. 2). The lines possessed multiple lamel-
lipodial extensions and pronounced membrane rufﬂing (not
shown).
EcR/3T3 cells were transfected with L61Rac1 under the control
of an ecdysone promoter. When Ponasterone A (an ecdysone ana-
logue) was included in the confronted explants assay, the inva-
sion index increased over that obtained with untreated cells
(Table 1b).
Rac1 activity was downregulated in three ways. Firstly,
NIH3T3 cells were transfected with dominant-negative N17Rac1
and three clones isolated. Dominant-negative Rac1 binds
strongly to guanine nucleotide exchange factors and conse-
quently inhibits the activation of endogenous Rac1. RT-PCR
indicated that the three lines were transcribing the NI7Rac1 gene
(Supplementary Fig. 3). All three lines were more invasive
than the control cells in the confronted explants assay (Table
2a).
Endogenous Rac1 activity was also blocked in NIH3T3 cells
using NSC23766, a Rac1-speciﬁc inhibitor which binds speciﬁ-
cally to the GEF binding site of Rac1, preventing activation by
Trio and Tiam1 [12]. Increased invasivity of the inhibitor-treated
cells was again observed, i.e. the invasive index increased (Table
2b).
Tiam1 is a Rac1-speciﬁc GEF and downregulation of Tiam1
expression would be expected to result in a decrease in the level
of activated Rac1 in the cell. Antisense Tiam1 was transfected in
NIH3T3 cells and three lines isolated. RT-PCR showed that the
level of Tiam1 mRNA was down-regulated in all three lines
(Supplementary Fig. 4). All three lines exhibited increases
Table 2
Effect of reducing levels of activated Rac1 on the invasion index of NIH3T3 cells. (a)
Three lines transfected with N17Rac1. Cell line NIH3T3/VV4 is the empty vector
control. (b) NIH3T3 cells treated with the Rac1-speciﬁc inhibitor NSC23766 (25 lM).
(c) Three cell lines transfected with an antisense Tiam1 construct. pcDNA3.1 is the
control cell line.
Cell line n Mean invasion index ± std error p-value
(a)
N17Rac1(1) 31 0.69 ±0.03 0.00
N17Rac1(2) 27 0.59 ±0.03 0.00
N17Rac1(3) 24 0.61 ±0.02 0.00
NIH3T3/VV4 29 0.43 ±0.02
(b)
NIH3T3 + NSC23766 24 0.61 ± 0.04 0.00
NIH3T3 19 0.46 ± 0.03
(c)
Antisense Tiam1 (1) 13 0.61 ± 0.04 0.00
Antisense Tiam1 (2) 12 0.64 ± 0.04 0.00
Antisense Tiam1 (3) 15 0.71 ± 0.03 0.00
pcDNA3.1 17 0.43 ± 0.03
Table 4
Effect on their invasive index of down-regulating RhoA or RhoC activity in N17Rac1
transfected NIH3T3 cells.
Cell line n Mean invasion index ± std error p-value
N17Rac1/p190RhoA(1) 18 0.52 ± 0.04 0.00
N17Rac1/p190RhoA(2) 19 0.46 ± 0.02 0.00
N17Rac1/p190RhoC(1) 21 0.65 ± 0.04 0.63
N17Rac1/p190RhoC(2) 19 0.67 ± 0.03 0.87
N17Rac1 31 0.67 ± 0.02
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3.2. Changes in Cdc42 activity do not inﬂuence heterotypic CIL
Cdc42 is active at the front of migrating cells and hence impli-
cated in cell polarity [13]. The invasion indices of lines transfected
with either the constitutively-active V12Cdc42 gene (two lines) or
the dominant-negative N17Cdc42 gene (three lines) were not sig-
niﬁcantly different statistically from the empty vector control
NIH3T3 cells (Supplementary Table 3). All lines transfected with
the Cdc42 genes expressed the relevant gene (Supplementary
Fig. 5).
3.3. Increased RhoA activity reduces heterotypic CIL
NIH3T3 cells were transfected with constitutively active
V14RhoA. Three lines were isolated and all expressed the V14RhoA
gene (Supplementary Fig. 6). All three lines had higher invasion
indices than the empty vector control (Table 3).
We hypothesized that the increased invasivity of N17Rac1 cells
and cells transfected with antisense Tiam1 (Table 2a and c) may be
due to RhoA activation. The levels of active RhoA were determined
in the NIH3T3 (empty vectors) and N17Rac1 and V14RhoA transfec-
ted cells. A doubling of the amount of RhoA-GTP was observed in
both cell lines (Supplementary Fig. 7a,b). Similarly, an increase in
RhoA-GTP levels was detected in antisense Tiam1 cells (Supple-
mentary Fig. 7c).
Are these increases in RhoA-GTP responsible for the increased
invasion indices of the cells?
Constructs combining the p190RhoGAP with the C-terminal end
of RhoA, B or C have been shown to down-regulate the respective
Rho activity when transfected into cells [14]. We transfected
N17-Rac1 NIH3T3 cells with the p190-RhoA construct and foundTable 3
Effect of constitutively active V14RhoA on the invasive index of NIH3T3 cells. NIH3T3/
VV4 is the empty vector control line.
Cell line n Mean invasion index ± std error p-value
V14RhoA(1) 19 0.73±0.03 0.00
V14RhoA(2) 19 0.62±0.03 0.00
V14RhoA(3) 10 0.55±0.03 0.04
NIH3T3/VV4 41 0.44±0.02invasion indices of the two lines isolated were reduced and the
differences to N17-Rac1 cells statistically signiﬁcant (Table 4). On
the other hand, cells expressing N17-Rac1 and transfected with
p190RhoC exhibited no statistically signiﬁcant change in their inva-
sive indices when compared to the N17-Rac1 control cells (Table 4).
RT-PCR conﬁrmed that the introduced genes were expressed in all
the lines tested (results not shown).
NIH3T3 cells were transfected with p190RhoA or p190RhoC and
invasion indices were not signiﬁcantly different statistically from
the control lines (results not shown).
To conﬁrm that p190-RhoA transfected N17Rac1 NIH3T3 cells
did indeed possess lower levels of RhoA-GTP than N17-RhoA cells,
the amounts of RhoA-GTP were determined. Active RhoA levels
were signiﬁcantly decreased in the N17Rac1-p190RhoA line (Sup-
plementary Fig. 7d).
3.4. Effects of inhibiting ROCK or activating mDia on the heterotypic
CIL of N17Rac1 cells
How might RhoA be inﬂuencing heterotypic CIL? RhoA has a
number of effectors, the two major ones being ROCK (Rho-associ-
ated coiled-coil forming kinase) and mDia [15,16]. Hence, the loss
of contact inhibition of locomotion in cells with increased levels of
RhoA-GTP may be a response to signaling along either of these
pathways. The ROCK inhibitor Y-27632, which competitively binds
to the ATP site at the catalytic site, was added to the confronted
explants assay but the mean invasive index was not signiﬁcantly
different statistically from the untreated N17Rac1 cells (Table 5).
A dominant-negative mDia construct was not available to us.
However, dominant-active mDia was transfected into NIH3T3
cells and the two lines tested were found to have increased
invasive indices in the confronted explants assay (Table 6a). On
the other hand, N17Rac1 cells (two lines) transfected with
dominant-active mDia exhibited reduced invasion indices com-
pared to the N17Rac1 cells (Table 6b). RT-PCR conﬁrmed the
expression of the dominant-active mDia gene in all the transfec-
ted lines studied (Supplementary Fig. 8a and b). Active RhoA lev-
els were reduced in a NI7Rac1d.a.mDia line (Supplementary
Fig. 7d).
3.5. Effects of down-regulation of p120-catenin or N-cadherin
NIH3T3 cells in which p120-catenin gene expression has been
down-regulated (p120i cells) were signiﬁcantly more invasive than
control lines which carried the human and not the murine siRNA
construct (Table 7a). Two NIH3T3 cell lines in which N-cadherin
had been rendered deﬁcient using stable siRNA expression [17]Table 5
Effect of the ROCK inhibitor Y27632 (25 lM) on the invasive index of N17Rac1 NIH3T3
cells.
Cell line & Treatment n Mean invasion index ± std error p-value
N17Rac1(1) + Y27632 18 0.59 ± 0.04 0.11
N17Rac1 (1) 15 0.68 ± 0.05
Table 6
Effect of dominant active mDia on the invasive indices of NIH3T3 cells and N17Rac1
transfected NIH3T3 cells. (a) Two NIH3T3 cell lines transfected cells dominant active
mDia. NIH3T3/VV4 is the empty vector control cell line. (b) Two N17Rac1 cell lines
transfected with dominant active mDia.
Cell line n Mean invasion index ± std error p-value
(a)
mDia(1) 17 0.58 ± 0.03 0.00
mDia(2) 14 0.64 ± 0.04 0.00
NIH3T3/VV4 41 0.44 ± 0.03
(b)
N17Rac1/mDia(1) 9 0.47 ± 0.05 0.00
N17Rac1/mDia(2) 13 0.46 ± 0.03 0.00
N17Rac1 31 0.69 ± 0.03
Table 7
Effect of reducing p120-catenin or N-cadherin levels on the invasion index of NIH3T3
cells. (Growing cultures were provided by A. Reynolds, Vanderbilt University). (a)
p120i cells compared with pRa-hp120 NIH3T3 cells. The latter are controls
transfected with the human rather than the murine siRNA construct. (b) Two N-
cadherin deﬁcient NIH3T3 cell lines compared with a control line (NIH3T3 PolyB)
with a mismatched siRNA.
Cell line n Mean invasion
index ± std error
p-value
(a)
p120i 15 0.67 ± 0.04 0.00
pRa-hp120 16 0.52 ± 0.03
(b)
mNcad GB2 8 0.81 ± 0.07 0.03
mNcad GB5 11 0.81 ± 0.06 0.02
NIH 3T3 PolyB 9 0.62 ± 0.04
Fig. 1. A model of heterotypic CIL following cadherin engagement. See text for
details.
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(Table 7b). The reason for the relatively high invasion indices of
the control lines is not known.
4. Discussion
The aim of this work was to ascertain the effects of changing the
activity of the three RhoGTPases Rac1, RhoA and Cdc42 on hetero-
typic CIL using the mouse ﬁbroblast/chicken heart ﬁbroblast con-
fronted explant assay devised by Abercrombie and colleagues [1].
All three proteins are involved in actin polymerization and have
been shown to be localized in the cell leading edge during protru-
sion formation [18–22]. We found both increasing (V12Rac1) and
lowering (N17Rac1) activity resulted in defective heterotypic CIL.
The former might be expected as activated Rac1 by itself is sufﬁ-
cient to induce lamellipodium extrusion [23]. Lowering Rac1 activ-
ity resulted in an increase in RhoA activity and we found increased
RhoA activity (V14RhoA) also gave rise to defective heterotypic CIL.
RhoA was thought to be predominantly involved in tail retraction
of migrating cells [24], however, recent studies suggest RhoA
may participate in both membrane protrusion and retraction at
the leading edge [20,25]. Cells expressing dominant active mDia
became more invasive, possibly because mDia activates Rac1
[26]. N17Rac1 cells had decreased invasion indices and reduced
levels of active RhoA, probably because mDia is activating endoge-
nous Rac1.
In mouse embryo ﬁbroblasts during spontaneous cell motility
the periodicity of the protrusion and retraction cycle at the cell
edge is approximately 100 s [20]. RhoA is activated during the pro-
trusion phase whereas Rac1 and Cdc42 activation lags edge protru-
sion, reaching their peak activation 40 s after protrusion has
commenced. Rac1 activity remained signiﬁcant during the retrac-
tion phase. Hence, RhoA appears to be responsible for initiating ac-tin polymerization at the commencement of the protrusion-
retraction cycle. Rac1 acts as an antagonist to RhoA since rapid
suppression of RhoA takes place as maximum Rac1 activation
occurs. During cell protrusion RhoA may activate formins such as
mDia to initiate actin polymerization rather than mediating
contractility via ROCK. While RhoA activation occurs as a band
2 lm from the leading edge, Cdc42 and Rac1 peak 1.8 lm behind
the leading edge of the protrusion close to the sites of maturing
adhesions. Hence, the authors suggest the latter two GTPases
may regulate adhesion dynamics [20]. If similar spatiotemporal
coordination occurs between RhoA and Rac1 in the protrusions of
NIH3T3 cells, increased RhoA activity could be affecting hetero-
typic CIL by disrupting the retraction phase of the cycle.
The RhoA signalling responsible for the loss of heterotypic CIL is
apparently not via ROCK in N17Rac1 cells as the ROCK inhibitor
Y-27632 did not reinstate CIL. Y-27632 inhibits homotypic CIL in
NC cells [3]. Transient RhoA activation may be required for both
types of CIL while constitutive activation interferes with CIL.
During transendothelial migration, frequent transient activa-
tion of RhoA occurs at the leading edge of T-cells [25]. RhoA activa-
tion precedes both membrane extension and retraction. Different
effector complexes may be responsible for RhoA contributing to
both extension and retraction at the leading edge.
Cadherins and nectins are cell adhesion proteins that have also
been implicated in the CIL response [27–30]. Initial E-cadherin
cell-cell adhesion results in increased Rac1 activity [31–33]. Cell–
cell collisions between the NIH3T3 cells and CHFwould presumably
result in N-cadherin trans-interactions at cell-cell contacts, giving
rise to Rac1 activation [17,30]. Rac1 activation causes enhancement
of ROS production, redox inhibition of low-MW protein tyrosine
phosphatase and consequent phosphorylation of p190RhoAGAP
which downregulates RhoA [17,34]. The NIH3T3 lines in which
N-cadherin had been rendered deﬁcient using stable siRNA expres-
sion exhibited diminished heterotypic CIL. The pathway by which
Rac1 inactivates RhoA is blocked and these lines have already been
shown to have increased levels of RhoA [17]. Blocking N-cadherin
on NC cells prevented homotypic CIL and groups of cells invaded
each other and overlapped [10]. In NIH3T3 ﬁbroblasts the increased
Rac1 activity results in p190RhoGAP translocation to adherens
junctions (AJs) where it associates with the cadherin complex via
transient binding to p120-catenin [17]. Localized inhibition of RhoA
results. The increased invasion index of 120-catenin deﬁcient cells
presumably reﬂects the inability of cell-cell contact to downregu-
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Depending on the cell type, different mechanisms to regulate
CIL may be involved. In metastatic prostate (PC-3) cells RhoA
activation due to the engagement of ephrin-A ligands and EphrinA
receptors activates RhoA leading to actomyosin contraction and
lamella withdrawal, i.e. homotypic CIL [36]. Fibroblast ephrin-B
ligands interact with PC-3 EphrinB receptors, triggering sustained
activation of Cdc42 and ﬁlipodia extension, thereby stimulating
PC-3 cell migration and leading to defective CIL [36]. Paradoxically,
ephrin-B2 mediates repulsion through EphB4 in ﬁbroblasts and
endothelial cells [37]. However, neither dominant active nor dom-
inant negative Cdc42 inﬂuenced the heterotypic CIL of NIH3T3
cells in our system. Similarly, Cdc42 does not appear to be involved
in the polarization and protrusion formation of NC cells [38].
A possible model for heterotypic CIL between NIH3T3 ﬁbro-
blasts and chicken heart ﬁbroblasts is that cell-cell contact (N-cad-
herin engagement) induces rapid Rac1 activation which inactivates
RhoA at the site of contact via the ROS/p190RhoAGAP pathway
(Fig. 1). Initiation of protrusions (i.e. via formin-induced actin poly-
merization) is consequently blocked until Rac1 is downregulated.
RhoGEFs may be recruited away from the contact sites and initiate
adjacent protrusions via mDia induced actin polymerization. Alter-
natively, levels of activated Rac1 may eventually decrease at the
contact site [30]. While a constitutively active form of Rac1 persists
at cell contacts, a loss of both Rac1 and active Rac1 from newly
formed MDCK cell contacts occurs within 5 min of E-cadherin
recruitment [39]. RhoA activity would then increase and could re-
sult in membrane retraction via ROCK and myosin light chain (p-
MLC) phosphorylation [40]. The mechanism determining which
of the two RhoA pathways is activated at the leading edge is not
known but may depend on the localization of effectors and/or
the levels of RhoA activity [40].
Cells exhibiting heterotypic CIL do not necessarily display
homotypic CIL [2]. None of the cell lines we studied showing
diminished heterotypic CIL appeared to have faulty homotypic
CIL. Either two different systems are involved as is the case with
the EphA and EphB signalling pathways or mechanisms are in place
to ameliorate the effects of constitutive Rac1 or RhoA activities.
Live imaging experiments clarifying the localization of these vari-
ous regulatory proteins during heterotypic and homotypic CIL are
needed.
Our results suggest that interfering with the reciprocal control
(mutual antagonism) between Rac1 and RhoA leads to defective
heterotypic CIL between the NIH3T3 and chicken heart ﬁbroblasts,
probably by disturbing the periodicity of RhoA/Rac1 dynamics in
the protrusion-retraction cycle.
Malignant mesenchymal cells exhibit a reduced CIL response,
their invasion of ﬁbroblast cultures resembling metastasis [1,4].
Loss of the RhoA/Rac1 balance might be involved. No constitutively
active forms of RhoGTPases have been detected in human tumours.
However, many such tumours exhibit increased expression of
RhoGTPases, including RhoA and Rac1 (reviewed in [41,42]). This
overexpression would be expected to correlate with increased
activation. Strong expression of the GEFs Vax, Trio and Tiam-1
were detected in breast tumours with poor prognosis [43]. Rac1
overexpression correlates with the progression of testicular,
gastric, breast, colorectal and oral squamous cell cancers [41].
Increased RhoA expression has been described in human liver, skin,
colon, ovarian, gastric, oesophageal, squamous cell and testicular
cancer [41,42]. Overexpression of RhoA in ovarian cancer cells
results in increased metastases when cells are injected into the
peritoneal cavity [44]. A role for RhoA in tumour invasion and
metastasis is also supported by the discovery that RhoA is active
in membrane protrusions and promotes invadopodia and amoe-
boid migration [45]. Formation of human breast adenocarcinomainvadopodia in both two- and three- dimensional matrices re-
quires RhoA and Cdc42, possibly by regulating mDia function in
actin polymerization [46].
During in vivo invasion of rat ductal adenocarcinoma cells dri-
ven by mutant p53, high RhoA activity is present at the leading
edge and rear of the cells [47]. Non-invasive cells lacked the pool
of active RhoA and an anti-invasive agent (dasatanib) inhibited
RhoA activity at the poles of the cells. Our results are consistent
with a loss of heterotypic CIL resulting from high RhoA activity
playing a role in cancer cell invasion.Acknowledgements
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